Triple-Negative Myeloproliferative Neoplasms Vs. Calr, JAK2 or MPL-Mutated Myeloproliferative Neoplasms: Distinct Molecular Characteristics

被引：0

作者：

Yun, Jiwon ^{[1
]}

Kim, Jung-Ah ^{[2
]}

Hwang, Byungjin ^{[3
]}

Park, Hee Sue ^{[4
]}

Im, Kyongok ^{[5
,6
]}

Kim, Sung-Min ^{[7
]}

Jeong, Dajeong ^{[1
]}

Lim, Kyu Min ^{[7
]}

Bang, Duhee ^{[3
]}

Lee, Dong Soon ^{[1
]}

机构：

[1] Seoul Natl Univ Hosp, Dept Lab Med, Seoul, South Korea

[2] Chung Ang Univ Hosp, Dept Lab Med, Seoul, South Korea

[3] Yonsei Univ, Dept Chem, Coll Nat Sci, Seoul, South Korea

[4] Chungbuk Natl Univ Hosp, Dept Lab Med, Seoul, South Korea

[5] Inst Reprod Med, Seoul, South Korea

[6] Populat Med Res Ctr, Seoul, South Korea

[7] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea

来源：

BLOOD | 2018年 / 132卷

关键词：

Myeloproliferative neoplasms; next-generation sequencing; triple negative MPN; chromosome; FISH; telomere;

D O I：

10.1182/blood-2018-99-118013

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1772

引用

页数：3

共 50 条

[21] Molecular characterization of triple-negative myeloproliferative neoplasms by next-generation sequencing
Madhavi Maddali
Arvind Venkatraman
Uday Prakash Kulkarni
Sathya Mani
Santhosh Raj
Elanthenral Sigamani
Anu Korula
Fouzia N A
Sharon Anbumalar Lionel
Sushil Selvarajan
Marie Therese Manipadam
Aby Abraham
Biju George
Vikram Mathews
Poonkuzhali Balasubramanian
Annals of Hematology, 2022, 101 : 1987 - 2000
[22] Parallel algorithm for myeloproliferative neoplasms testing: the frequency of double mutations is found in the JAK2/MPL genes more often than the JAK2/CALR genes, but is there a clinical benefit?
Gorbenko, Aleksey S.
Stolyar, Marina A.
Olkhovskiy, Igor A.
Vasiliev, Evgeniy V.
Mikhalev, Mikhail A.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2019, 57 (04) : E60 - E62
[23] Low JAK2 V617F Allele Burden in Ph-Negative Chronic Myeloproliferative Neoplasms Is Associated with Additional CALR or MPL Gene Mutations
Makarik, Tatiana, V
Abdullaev, Adhamjon O.
Nikulina, Elena E.
Treglazova, Svetlana A.
Stepanova, Elena E.
Subortseva, Irina N.
Kovrigina, Alla M.
Melikyan, Anait L.
Kulikov, Sergei M.
Sudarikov, Andrey B.
GENES, 2021, 12 (04)
[24] Validation of a molecular diagnostic assay for CALR exon 9 indels in myeloproliferative neoplasms: identification of coexisting JAK2 and CALR mutations and a novel 9 bp deletion in CALR
Murugesan, G.
Guenther-Johnson, J.
Mularo, F.
Cook, J. R.
Daly, T. M.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 (03) : 284 - 297
[25] Oncogenic Drivers in Myeloproliferative Neoplasms: From JAK2 to Calreticulin Mutations
Xavier Cahu
Stefan N. Constantinescu
Current Hematologic Malignancy Reports, 2015, 10 : 335 - 343
[26] The Contribution of JAK2 46/1 Haplotype in the Predisposition to Myeloproliferative Neoplasms
Paes, Jhemerson
Silva, George A., V
Tarrago, Andrea M.
de Souza Mourao, Lucivana P.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
[27] Oncogenic Drivers in Myeloproliferative Neoplasms: From JAK2 to Calreticulin Mutations
Cahu, Xavier
Constantinescu, Stefan N.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2015, 10 (04) : 335 - 343
[28] The role of Janus kinase 2 (JAK2) in myeloproliferative neoplasms: Therapeutic implications
Quintas-Cardama, Alfonso
LEUKEMIA RESEARCH, 2013, 37 (04) : 465 - 472
[29] The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience
Najm, Maysam Basim
Jalal, Sana Dlawar
Getta, Hisham Arif
CELLULAR AND MOLECULAR BIOLOGY, 2022, 68 (08) : 202 - 209
[30] CALR gene mutational profile in myeloproliferative neoplasms with non-mutated JAK2 in Moroccan patients: A case series and germline in-frame deletion
Smaili, W.
Doubaj, Y.
Laarabi, F. Z.
Lyahyai, J.
Kerbout, M.
Mikdame, M.
Sefiani, A.
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2017, 65 (01) : 15 - 19

← 1 2 3 4 5 →